J&J's Janssen Hit With $70 Mln Verdict in Risperdal TrialJ&J's Janssen Hit With $70 Mln Verdict in Risperdal Trial
A U.S. jury has awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal (risperidone). Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2016 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Severely aggressive children receiving stimulant medication versus stimulant and risperidone: 12-month follow-up of the TOSCA Trial - Gadow KD, Brown NV, Arnold LE, Buchan-Page KA, Bukstein OG, Butter E, Farmer CA, Findling RL, Kolko DJ, Molina BS, Rice RR, Schneider J, Aman MG.
The objective of this study was to evaluate 52-week clinical outcomes of children with co-occurring attention-deficit/hyperactivity disorder (ADHD), disruptive behavior disorder, and serious physical aggression who participated in a prospective,... (Source: SafetyLit)
Source: SafetyLit - June 15, 2016 Category: Global & Universal Tags: Age: Adolescents Source Type: news
Resperidone (depot) for schizophrenia
Risperidone is the first new generation antipsychotic drug made available in a long-acting injection formulation.
To examine the effects of depot risperidone for treatment of schizophrenia or related psychoses in comparison with placebo, no treatment or other antipsychotic medication.
To critically appraise and summarise current evidence on the resource use, cost and cost-effectiveness of risperidone (depot) for schizophrenia. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 12, 2016 Category: Consumer Health News Source Type: news
Drug and behavioural therapy are both effective for tics in people with Tourette syndrome
There are effective drug and behavioural treatments for tics in children and young people with Tourette syndrome. Although most of the studies included in this review were small with risk of , the effects found were moderate to large and likely to be clinically meaningful.
This NIHR funded and qualitative study found that habit reversal therapy, where people with Tourette's are taught to replace their tic with a less noticeable alternative, was effective. The drugs with the best balance of benefits and harms – risperidone, clonidine and aripiprazole – are those most commonly used in the UK. (Source: Current Awareness ...
Source: Current Awareness Service for Health (CASH) - April 7, 2016 Category: Consumer Health News Source Type: news
Risperdal (Risperidone) - What You Need to Know
(Source: About.com Mental Health)
Source: About.com Mental Health - March 16, 2016 Category: Psychiatry Tags: health Source Type: news
Zydus Pharma Inc recalls 9,504 bottles of Risperidone tablets
Risperidone tablets are used in the treatment of schizophrenia. "The reason for recall is "out of specification for a known degradant," it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 7, 2016 Category: Pharmaceuticals Source Type: news
Improving symptoms and side effects in older patients with schizophrenia with decreasing dopamine D2/3 receptor occupancy following resperidone and olanzapine dose reduction
The use of lower doses of antipsychotics is recommended by experts in the treatment of older patients with schizophrenia, with the literature suggesting that older age is related to greater antipsychotic sensitivity.1 To date, three randomised controlled trials have examined the effects of olanzapine and risperidone dose reduction on clinical outcome in schizophrenia with inconsistent results.2–4 However, this topic has not been addressed specifically in older patients with schizophrenia, nor has the relationship between ...
Source: Current Awareness Service for Health (CASH) - March 3, 2016 Category: Consumer Health News Source Type: news
Risperidone, aripiprazole treat irritability in children with ASD
Risperidone and aripiprazole, followed by N-acetylcysteine, appear most effective in treating irritability and aggression in youth with autism spectrum disorders (ASD), according to a systematic... (Source: Pediatric News)
Source: Pediatric News - March 2, 2016 Category: Journals (General) Source Type: news
Risperidone, aripiprazole treat irritability in children with ASD
Risperidone and aripiprazole, followed by N-acetylcysteine, appear most effective in treating irritability and aggression in youth with autism spectrum disorders (ASD), according to a systematic... (Source: Family Practice News)
Source: Family Practice News - March 2, 2016 Category: Primary Care Source Type: news
Mother in Yorkshire accidentally given pills to treat schizophrenia
Henryka Barszczowska, 60, from Roundhay, West Yorkshire, suffers from restless legs syndrome and expected a prescription to treat that - but instead was given anti-psychotic drug risperidone. (Source: the Mail online | Health)
Source: the Mail online | Health - February 2, 2016 Category: Consumer Health News Source Type: news
Yes, The Calorie Is Broken. Here's Why.
“For me, a calorie is a unit of measurement that’s a real pain in the rear.” Bo Nash is 38. He lives in Arlington, Texas, where he’s a technology director for a textbook publisher. And he’s 5’10” and 245 pounds – which means he is classed as obese. In an effort to lose weight, Nash uses an app to record the calories he consumes and a Fitbit band to track the energy he expends. These tools bring an apparent precision: Nash can quantify the calories in each cracker crunched and stair climbed. But when it comes to weight gain, he finds that not all calories are equal. How ...
Source: Science - The Huffington Post - January 30, 2016 Category: Science Source Type: news
Yes, The Calorie Is Broken. Here's Why.
“For me, a calorie is a unit of measurement that’s a real pain in the rear.”
Bo Nash is 38. He lives in Arlington, Texas, where he’s a technology director for a textbook publisher. And he’s 5’10” and 245 pounds – which means he is classed as obese.
In an effort to lose weight, Nash uses an app to record the calories he consumes and a Fitbit band to track the energy he expends. These tools bring an apparent precision: Nash can quantify the calories in each cracker crunched and stair climbed. But when it comes to weight gain, he finds that not all calories are equal. How ...
Source: Science - The Huffington Post - January 30, 2016 Category: Science Source Type: news
A neuroligin-3 mutation implicated in autism causes abnormal aggression and increases repetitive behavior in mice - Burrows EL, Laskaris L, Koyama L, Churilov L, Bornstein JC, Hill-Yardin EL, Hannan AJ.
BACKGROUND: Aggression is common in patients with autism spectrum disorders (ASD) along with the core symptoms of impairments in social communication and repetitive behavior. Risperidone, an atypical antipsychotic, is widely used to treat aggression in ASD... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - November 28, 2015 Category: Global & Universal Tags: Age: Adolescents Source Type: news
Safety of Vraylar vs. Other Antipsychotics Drugs Compared in New Drug...
Comparative safety research review covers Abilify (Bristol-Meyers), Fanapt (Novartis), INVEGA (J&J), Risperdal (J&J), Risperdal Consta (Janssen)(PRWeb October 26, 2015)Read the full story at http://www.prweb.com/releases/2015/10/prweb13042760.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 26, 2015 Category: Pharmaceuticals Source Type: news
Big Pharma's Defeat Devices
"The worse the data on the elderly got, and the worse the potential for the FDA reaction to it got, the more J&J seemed to intensify its sales effort." So writes investigative journalist Steven Brill in his chilling, meticulously researched "docuserial" America's Most Admired Lawbreaker, concerning Johnson & Johnson's efforts to market the antipsychotic Risperdal off-label -- that is, without authorization -- to seniors with dementia and children diagnosed with pediatric bipolar disorder. The series ended its fifteen-day run on The Huffington Post last week. It follows the spring publication of Brill's compelling, widely ...
Source: Healthy Living - The Huffington Post - October 5, 2015 Category: Consumer Health News Source Type: news
